Cargando…
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan
Inhibiting tyrosyl-DNA phosphodiesterase 1 (TDP1) is a promising strategy for increasing the effectiveness of existing antitumor therapy since it can remove the DNA lesions caused by anticancer drugs, which form covalent complexes with topoisomerase 1 (TOP1). Here, new adamantane–monoterpene conjuga...
Autores principales: | Munkuev, Aldar A., Dyrkheeva, Nadezhda S., Kornienko, Tatyana E., Ilina, Ekaterina S., Ivankin, Dmitry I., Suslov, Evgeniy V., Korchagina, Dina V., Gatilov, Yuriy V., Zakharenko, Alexandra L., Malakhova, Anastasia A., Reynisson, Jóhannes, Volcho, Konstantin P., Salakhutdinov, Nariman F., Lavrik, Olga I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182348/ https://www.ncbi.nlm.nih.gov/pubmed/35684313 http://dx.doi.org/10.3390/molecules27113374 |
Ejemplares similares
-
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
por: Munkuev, Aldar A., et al.
Publicado: (2021) -
New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition
por: Dyrkheeva, Nadezhda S., et al.
Publicado: (2021) -
New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan
por: Khomenko, Tatyana M., et al.
Publicado: (2023) -
New Myrtenal–Adamantane Conjugates Alleviate Alzheimer’s-Type Dementia in Rat Model
por: Dragomanova, Stela, et al.
Publicado: (2022) -
A practical way to synthesize chiral fluoro-containing polyhydro-2H-chromenes from monoterpenoids
por: Mikhalchenko, Oksana S, et al.
Publicado: (2016)